Dashboard
Manage Tickers

ASLNASLAN Pharmaceuticals Ltd

Nasdaq www.aslanpharma.com


$ 0.37 $ -0.04 (-9.76 %)    

Monday, 17-Jun-2024 14:49:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 486.63 $ 6.67 (1.39 %)
DIA $ 388.82 $ 3.76 (0.98 %)
SPY $ 548.30 $ 6.22 (1.15 %)
TLT $ 93.68 $ -0.18 (-0.19 %)
GLD $ 214.48 $ -0.40 (-0.19 %)
$ 0.41
$ 0.42
$ 0.00 x 0
$ 0.37 x 100
$ 0.35 - $ 0.42
$ 0.39 - $ 4.23
214,266
na
50.07M
$ 1.69
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

aslan-pharmaceuticals-announces-plan-to-implement-ads-ratio-change-from-1-ads-representing-25-shares-to-1-ads-representing-200-shares-1-for-8-ads-split-effective-date-for-the-ratio-change-july-3-2024
ASLAN Pharmaceuticals Announces Plan To Im...
06/14/2024 21:00:55

ASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmac...

aslan-pharmaceuticals-announces-late-breaking-poster-presentation-of-translational-data-on-eblasakimab-at-american-thoracic-society-international-conference
ASLAN Pharmaceuticals Announces Late-Break...
05/21/2024 11:07:04

aslan-pharma-q1-2024-gaap-epads-129-misses-061-estimate
ASLAN Pharma Q1 2024 GAAP EPADS $(1.29) Mi...
05/09/2024 11:51:49

hc-wainwright--co-reiterates-buy-on-aslan-pharma-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on ASLA...
05/03/2024 19:17:04

HC Wainwright & Co. analyst Yi Chen reiterates ASLAN Pharma (NASDAQ:ASLN) with a Buy and maintains $9 price target.

aslan-pharmaceuticals-announces-expansion-of-its-collaboration-with-zenyaku-to-investigate-the-biology-underlying-differential-effects-of-eblasakimab-compared-to-other-biologics
ASLAN Pharmaceuticals Announces Expansion ...
05/02/2024 13:11:18

New research collaboration will explore the differentiation of eblasakimab's mechanism of action versus biologic therapies ...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/26/2024 20:31:15

aslan-pharmaceuticals-disclosed-late-breaking-abstract-on-eblasakimab-in-copd-accepted-for-presentation-at-the-american-thoracic-society-international-conference
ASLAN Pharmaceuticals Disclosed Late Break...
04/24/2024 11:17:04

hc-wainwright--co-reiterates-buy-on-aslan-pharma-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on ASLA...
04/23/2024 10:15:47

HC Wainwright & Co. analyst Yi Chen reiterates ASLAN Pharma (NASDAQ:ASLN) with a Buy and maintains $9 price target.

aslan-pharmaceuticals-reports-interim-results-from-phase-2-study-of-eblasakimab-in-dupilumab-experienced-atopic-dermatitis-patients
Aslan Pharmaceuticals Reports Interim Resu...
04/22/2024 12:33:58

https://www.sec.gov/Archives/edgar/data/1722926/000095017024046201/asln-ex99_1.htm 

hc-wainwright--co-reiterates-buy-on-aslan-pharma-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on ASLA...
04/15/2024 12:02:34

HC Wainwright & Co. analyst Yi Chen reiterates ASLAN Pharma (NASDAQ:ASLN) with a Buy and maintains $9 price target.

hc-wainwright--co-maintains-buy-on-aslan-pharma-lowers-price-target-to-9
HC Wainwright & Co. Maintains Buy on ASLAN...
03/18/2024 11:04:32

HC Wainwright & Co. analyst Yi Chen maintains ASLAN Pharma (NASDAQ:ASLN) with a Buy and lowers the price target from $17...

piper-sandler-reiterates-overweight-on-aslan-pharma-lowers-price-target-to-10
Piper Sandler Reiterates Overweight on ASL...
03/13/2024 13:29:57

Piper Sandler analyst Edward Tenthoff reiterates ASLAN Pharma (NASDAQ:ASLN) with a Overweight and lowers the price target fr...

piper-sandler-maintains-overweight-on-aslan-pharma-lowers-price-target-to-10
Piper Sandler Maintains Overweight on ASLA...
03/13/2024 11:41:56

Piper Sandler analyst Edward Tenthoff maintains ASLAN Pharma (NASDAQ:ASLN) with a Overweight and lowers the price target fro...

correction-aslan-pharmaceuticals-announces-5-million-registered-direct-offering
CORRECTION: ASLAN Pharmaceuticals Announce...
03/12/2024 19:17:41

aslan-pharmaceuticals-shares-resume-trading
ASLAN Pharmaceuticals Shares Resume Trading
03/11/2024 19:07:16

aslan-pharmaceuticals-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-1352
ASLAN Pharmaceuticals Shares Halted On Cir...
03/11/2024 19:02:33

aslan-pharmaceuticals-shares-resume-trade
ASLAN Pharmaceuticals Shares Resume Trade
03/11/2024 19:01:27

piper-sandler-maintains-overweight-on-aslan-pharma-maintains-15-price-target
Piper Sandler Maintains Overweight on ASLA...
03/11/2024 19:01:27

Piper Sandler analyst Edward Tenthoff maintains ASLAN Pharma (NASDAQ:ASLN) with a Overweight and maintains $15 price target.

aslan-pharmaceuticals-shares-halted-on-circuit-breaker-stock-now-up-792
ASLAN Pharmaceuticals Shares Halted On Cir...
03/11/2024 18:52:01

aslan-pharmaceuticals-shares-resume-trade-shares-spike-higher
ASLAN Pharmaceuticals Shares Resume Trade,...
03/11/2024 18:51:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)